Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("prior authorization")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 16 of 16

  • Page / 1
Export

Selection :

  • and

Facilitators and barriers to implementing antimicrobial stewardship strategies: Results from a qualitative studyPAKYZ, Amy L; MOCZYGEMBA, Leticia R; VANDERWIELEN, Lynn M et al.American journal of infection control. 2014, Vol 42, Num 10, issn 0196-6553, S257-S263, SUPArticle

Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure dataGAMBLE, John-Michael; JOHNSON, Jeffrey A; MAJUMDAR, Sumit R et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 5, pp 551-555, issn 1053-8569, 5 p.Article

Management of Newer Medications for Attention-Deficit/Hyperactivity Disorder in Commercial Health PlansHODGKIN, Dominic; HORGAN, Constance M; QUINN, Amity E et al.Clinical therapeutics. 2014, Vol 36, Num 12, pp 2034-2046, issn 0149-2918, 13 p.Article

Antimicrobial Stewardship in Pediatric Care: Strategies and Future Directions : ANTIMICROBIAL STEWARDSHIPNEWLAND, Jason G; BANERJEE, Ritu; GERBER, Jeffrey S et al.Pharmacotherapy. 2012, Vol 32, Num 8, pp 735-743, issn 0277-0008, 9 p.Article

Retrospective Assessment of Medicaid Step-Therapy Prior Authorization Policy for Atypical Antipsychotic Medications. CommentaryRASCATI, Karen L; BROWN, Carolyn M; FARLEY, Joel F et al.Clinical therapeutics. 2008, Vol 30, Num 8, issn 0149-2918, 1506-1507, 1524-1539 [18 p.]Article

Management of access to branded psychotropic medications in private health plansHODGKIN, Dominic; HORGAN, Constance M; GARNICK, Deborah W et al.Clinical therapeutics. 2007, Vol 29, Num 2, pp 371-380, issn 0149-2918, 10 p.Article

Assessment of Changes in Utilization of Health-Care Services After Implementation of a Prior Authorization Policy for Atypical Antipsychotic AgentsWALTHOUR, Amy; SEYMOUR, Lynne; TACKETT, Randall et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 5, pp 809-818, issn 1060-0280, 10 p.Article

Appeals system and its outcomes in national health insurance in TaiwanLIN, Swu-Jane; KUO, Shih-Chen; KAO YANG, Yea-Huei et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 3, pp 506-511, issn 1060-0280, 6 p.Article

Potential Cost Savings for a Health System-Based Employee Outpatient PharmacyPHILLIPPE, Haley M; ANDRUS, Miranda R; SIMS, Matthew et al.Hospital pharmacy (Philadelphia, PA). 2010, Vol 45, Num 6, pp 472-477, issn 0018-5787, 6 p.Article

When gatekeepers meet the sentinel : The impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community-based physiciansKAHAN, Natan R; CHINITZ, David P; WAITMAN, Dan-Andrei et al.British journal of clinical pharmacology. 2006, Vol 61, Num 3, pp 341-344, issn 0306-5251, 4 p.Article

Impact of Two Medicaid Prior-Authorization Policies on Antihypertensive Use and Costs Among Michigan and Indiana Residents Dually Enrolled in Medicaid and Medicare: Results of a Longitudinal, Population-Based StudyLAW, Michael R; LU, Christine Y; SOUMERAI, Stephen B et al.Clinical therapeutics. 2010, Vol 32, Num 4, pp 729-741, issn 0149-2918, 13 p.Article

A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorderMCCOMBS, Jeffrey S; LIZHENG SHI; STIMMEL, Glen L et al.Clinical therapeutics. 2002, Vol 24, Num 11, pp 1939-1959, issn 0149-2918, 21 p.Article

Impact of Prior Authorization on the Use and Costs of Lipid-Lowering Medications Among Michigan and Indiana Dual Enrollees in Medicaid and Medicare: Results of a Longitudinal, Population-Based StudyLU, Christine Y; LAW, Michael R; SOUMERAI, Stephen B et al.Clinical therapeutics. 2011, Vol 33, Num 1, pp 135-144, issn 0149-2918, 10 p.Article

Modifying prescribing behaviour of angiotensin receptor blockers by selectively rescinding managerial prior authorization requirements for losartanKAHAN, Natan R; CHINITZ, David P; BLACKMAN, Shimon et al.British journal of clinical pharmacology. 2011, Vol 72, Num 6, pp 997-1001, issn 0306-5251, 5 p.Article

Pediatric Uptake of a Newly Available Antipsychotic MedicationPENFOLD, Robert B; KELLEHER, Kelly J; WEI WANG et al.Pediatrics (Evanston). 2010, Vol 125, Num 3, pp 475-482, issn 0031-4005, 8 p.Article

Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care medicaid populationHARTUNG, Daniel M; TOUCHETTE, Daniel R; KETCHUM, Kathy L et al.Clinical therapeutics. 2004, Vol 26, Num 9, pp 1518-1532, issn 0149-2918, 15 p.Article

  • Page / 1